ATE368669T1 - C-substituierte trizyklische isoxazolin derivate und deren verwendung als anti-depressiva - Google Patents

C-substituierte trizyklische isoxazolin derivate und deren verwendung als anti-depressiva

Info

Publication number
ATE368669T1
ATE368669T1 AT03787817T AT03787817T ATE368669T1 AT E368669 T1 ATE368669 T1 AT E368669T1 AT 03787817 T AT03787817 T AT 03787817T AT 03787817 T AT03787817 T AT 03787817T AT E368669 T1 ATE368669 T1 AT E368669T1
Authority
AT
Austria
Prior art keywords
depressants
substituted tricyclic
isoxazoline derivatives
tricyclic isoxazoline
derivatives
Prior art date
Application number
AT03787817T
Other languages
English (en)
Inventor
Jose Ignacio Andres-Gil
Jose Manuel Bartolome-Nebreda
Rosa Maria Alvarez-Escobar
Margaretha Bakker
Antonius Adrianus Hendr Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE368669T1 publication Critical patent/ATE368669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT03787817T 2002-08-12 2003-08-12 C-substituierte trizyklische isoxazolin derivate und deren verwendung als anti-depressiva ATE368669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02078322 2002-08-12

Publications (1)

Publication Number Publication Date
ATE368669T1 true ATE368669T1 (de) 2007-08-15

Family

ID=31725449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03787817T ATE368669T1 (de) 2002-08-12 2003-08-12 C-substituierte trizyklische isoxazolin derivate und deren verwendung als anti-depressiva

Country Status (15)

Country Link
US (1) US7465741B2 (de)
EP (1) EP1537124B1 (de)
JP (1) JP4681295B2 (de)
CN (1) CN1329396C (de)
AR (1) AR040967A1 (de)
AT (1) ATE368669T1 (de)
AU (1) AU2003262571B2 (de)
CA (1) CA2494235C (de)
DE (1) DE60315311T2 (de)
DK (1) DK1537124T3 (de)
ES (1) ES2290537T3 (de)
HK (1) HK1080080A1 (de)
PT (1) PT1537124E (de)
TW (1) TW200409777A (de)
WO (1) WO2004016621A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492796B1 (de) * 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva
ES2331144T3 (es) 2004-11-26 2009-12-22 Janssen Pharmaceutica Nv Derivados de isoxazolina-indol con actividad antipsicotica y ansiolitica mejorada.
CN102786515B (zh) * 2012-04-13 2014-07-23 湖南大学 2-（2,2-二甲基-2,3-二氢苯并呋喃-5-基）吗啉及其制备方法与应用
CN112374984A (zh) * 2020-11-06 2021-02-19 苏州求索生物科技有限公司 一种2-溴-4-羟基苯甲醚的制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361577B1 (de) * 1988-09-19 1993-05-05 Akzo N.V. Tetrahydronaphthalin und Indan-Derivate
GB9318691D0 (en) * 1993-09-09 1993-10-27 Merck Sharp & Dohme Therapeutic agents
AU681695B2 (en) 1993-09-15 1997-09-04 Merck Sharp & Dohme Limited Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
ATE246682T1 (de) * 1993-12-24 2003-08-15 Daiichi Suntory Pharma Co Ltd Benzothiazinderivate
JP3161737B2 (ja) 1996-01-05 2001-04-25 ヘキスト・マリオン・ルセル・インコーポレイテツド ＣＮＳ活性を有する４，５―ジヒドロナフト［１，２―ｃ］イソキサゾールおよびその誘導体
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
WO1997047601A1 (fr) * 1996-06-11 1997-12-18 Yoshitomi Pharmaceutical Industries, Ltd. Composes heterocycliques fusionnes et leurs utilisations medicinales
JP2003521443A (ja) * 1998-06-19 2003-07-15 ハー・ルンドベック・アクチエゼルスカベット ４，５，６及び７−インドール及びインドリン誘導体、その製造方法及びその使用方法
JP3953424B2 (ja) * 2001-02-21 2007-08-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗うつ薬としてのイソキサゾリン誘導体
EP1492796B1 (de) * 2002-04-02 2007-09-05 Janssen Pharmaceutica N.V. Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva
WO2004018482A2 (en) * 2002-08-21 2004-03-04 Janssen Pharmaceutica N.V. C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants

Also Published As

Publication number Publication date
JP4681295B2 (ja) 2011-05-11
TW200409777A (en) 2004-06-16
AU2003262571B2 (en) 2009-02-12
DK1537124T3 (da) 2007-10-29
DE60315311T2 (de) 2008-04-17
ES2290537T3 (es) 2008-02-16
EP1537124B1 (de) 2007-08-01
US7465741B2 (en) 2008-12-16
CN1675222A (zh) 2005-09-28
EP1537124A1 (de) 2005-06-08
AR040967A1 (es) 2005-04-27
US20050256119A1 (en) 2005-11-17
CA2494235C (en) 2011-10-11
CN1329396C (zh) 2007-08-01
JP2005537304A (ja) 2005-12-08
AU2003262571A1 (en) 2004-03-03
DE60315311D1 (de) 2007-09-13
PT1537124E (pt) 2007-10-16
HK1080080A1 (zh) 2006-04-21
WO2004016621A1 (en) 2004-02-26
CA2494235A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE395339T1 (de) Biphenylderivate und deren verwendung als fungizide
DE60308998D1 (de) N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel
ATE346056T1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
DE60113719D1 (de) Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DE602005004144D1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und deren verwendung als antivirale mitteln
ATE426597T1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
ATE367381T1 (de) Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren
ATE512965T1 (de) Pyrrolopyrimidin derivate
DE60326611D1 (de) N und dergleichen
ATE280163T1 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
DE60319951D1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DE60235492D1 (de) Beta-amino-alpha-cyanoacrylate und deren verwendung als herbizide
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
ATE418543T1 (de) Substituierte 1,4-dipiperidin-4-yl- piperazinderivate und deren verwendung als neurokininantagonisten
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
DE60336266D1 (de) Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl-piperazinderivate und deren verwendung als neurokinin antagonisten
ATE348805T1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
DE602004027811D1 (de) Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
DE50206476D1 (de) Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
ATE371653T1 (de) Benzoxazinderivate und deren verwendungen
DE602005007866D1 (de) 1-phenyl- und 1-pyridylpyrazolderivate und deren verwendung als pestizide
DE602004010284D1 (de) Aminochinolinderivate und deren verwendung als adenosin-a3-liganden
DE60311598D1 (de) Naphthyridin-derivate und ihre verwendung als fungizide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1537124

Country of ref document: EP

REN Ceased due to non-payment of the annual fee